Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study.

Lunde HMB, Assmus J, Myhr KM, Bø L, Grytten N.

J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):621-625. doi: 10.1136/jnnp-2016-315238. Epub 2017 Apr 1.

2.

Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.

Lunde HM, Torkildsen Ø, Bø L, Bertelsen AK.

Headache. 2016 Jun;56(6):1035-9. doi: 10.1111/head.12791. Epub 2016 Mar 17.

PMID:
26992044
3.

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Grytten N, Aarseth JH, Lunde HM, Myhr KM.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.

4.

Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.

Lunde HM, Bjorvatn B, Myhr KM, Bø L.

Acta Neurol Scand Suppl. 2013;(196):24-30. doi: 10.1111/ane.12046. Review.

PMID:
23190288
5.

Focal myositis--neurogenic phenomenon?

Lunde HM, Skeie GO, Bertelsen AK, Karlsen B, Miletic H, Lindal S, Brautaset NJ, Bindoff LA.

Neuromuscul Disord. 2012 Apr;22(4):350-4. doi: 10.1016/j.nmd.2011.10.023. Epub 2011 Dec 9.

PMID:
22153989

Supplemental Content

Loading ...
Support Center